Sorafenib-associated Trichodysplasia Spinulosa versus Follicular Hyperkeratosis: a case report

Reem Hasan, Nemat Alsaghir, Kinda Alshawa, Sajeda Alnabelsi, Hanaa Almsokar · 2025

Read Sorafenib-associated Trichodysplasia Spinulosa versus Follicular Hyperkeratosis: a case report by Reem Hasan, Nemat Alsaghir, Kinda Alshawa, Sajeda Alnabelsi, Hanaa Almsokar (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12741442.txt.

Description

Reem Hasan and co-authors report a spiky skin eruption in a patient taking the cancer drug sorafenib, in a 2025 case report. Sorafenib blocks several growth signals and treats advanced cancers such as liver cancer, but it often troubles the skin. The eruption matched trichodysplasia spinulosa, a rare condition of hair follicles usually tied to immune suppression, and never before pinned on this drug.

The close rival diagnosis was follicular hyperkeratosis, a plugging of follicles with keratin. The team lays out how the two differ and weighs which fits. They propose the drug scrambles keratin building in the skin, a risk sharpened in immunosuppressed patients. The report adds a face to watch for in clinics.

Catalog record

CREATORReem Hasan, Nemat Alsaghir, Kinda Alshawa, Sajeda Alnabelsi, Hanaa Almsokar
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE10 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12741442

Browse the full library · About the Tower of Babel